CG Oncology, Inc. - Common Stock (CGON) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CGON on Nasdaq
Shares outstanding
76,566,375
Price per share
$41.52
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
77,648,888
Total reported value
$3,127,517,509
% of total 13F portfolios
0.01%
Share change
+1,805,282
Value change
+$92,134,469
Number of holders
175
Price from insider filings
$41.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CG Oncology, Inc. - Common Stock (CGON) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 8.6% $264,932,879 6,577,281 The Vanguard Group 30 Sep 2025
Decheng Capital Global Life Sciences Fund IV, L.P. 8.4% $178,215,582 6,371,669 Xiangmin Cui 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 7.2% $222,054,738 5,512,779 Wellington Management Group LLP 30 Sep 2025
Longitude Capital Partners IV, LLC 6% $121,032,477 4,662,268 Patrick G. Enright 11 Sep 2025
Unique Diamond Investments Ltd 5.5% $117,791,208 4,211,341 SONG, Hong Fang 31 Dec 2024
FMR LLC 5.1% $100,262,786 3,856,261 FMR LLC 30 Jun 2025
TCG Crossover GP I, LLC 4.8% $102,655,662 3,670,206 TCG Crossover GP I, LLC 31 Mar 2025
Seven Fleet Capital Management LP 2% $62,145,313 1,542,833 Brian Liu 06 Oct 2025
Seven Fleet Partners LP 1.9% $39,333,320 1,515,151 Seven Fleet Partners LP 11 Sep 2025

As of 30 Sep 2025, 175 institutional investors reported holding 77,648,888 shares of CG Oncology, Inc. - Common Stock (CGON). This represents 101% of the company’s total 76,566,375 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CG Oncology, Inc. - Common Stock (CGON) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 8.6% 6,577,281 +11% 0% $264,932,879
Decheng Capital LLC 8.3% 6,371,669 0% 45% $256,650,827
WELLINGTON MANAGEMENT GROUP LLP 7.2% 5,512,779 +190% 0.04% $222,054,736
BlackRock, Inc. 6% 4,586,514 +2.9% 0% $184,744,784
FMR LLC 5% 3,865,802 +0.25% 0.01% $155,714,505
TCG Crossover Management, LLC 4.8% 3,670,206 0% 7.3% $147,835,898
BRAIDWELL LP 4.3% 3,283,317 0% 3.9% $132,252,009
Foresite Capital Management VI LLC 2.9% 2,221,474 0% 35% $89,480,973
ALLIANCEBERNSTEIN L.P. 2.8% 2,138,119 -1.2% 0.03% $86,123,433
UBS Group AG 2.8% 2,126,270 -4.6% 0.02% $85,646,154
STATE STREET CORP 2.7% 2,046,667 -5.5% 0% $82,439,747
Kynam Capital Management, LP 2.6% 2,005,205 -18% 6% $80,769,657
ORBIMED ADVISORS LLC 2.3% 1,726,850 -8% 1.7% $69,557,518
RTW INVESTMENTS, LP 2.2% 1,701,216 0% 0.84% $68,524,980
Avidity Partners Management LP 2.1% 1,600,899 +6.7% 15% $64,484,212
PRICE T ROWE ASSOCIATES INC /MD/ 2.1% 1,588,758 -21% 0.01% $63,996,000
Point72 Asset Management, L.P. 2% 1,523,409 +3.3% 0.13% $61,362,915
GEODE CAPITAL MANAGEMENT, LLC 1.9% 1,473,173 +10% 0% $59,350,411
FRANKLIN RESOURCES INC 1.9% 1,469,303 -1.2% 0.01% $59,183,533
GOLDMAN SACHS GROUP INC 1.8% 1,366,871 +15% 0.01% $55,057,564
Pictet Asset Management Holding SA 1.7% 1,318,567 -2.6% 0.05% $53,111,879
ACORN CAPITAL ADVISORS, LLC 1.5% 1,131,501 0% 23% $45,576,843
Polar Capital Holdings Plc 1.4% 1,098,662 0% 0.21% $44,254,105
Candriam S.C.A. 1.4% 1,037,892 +36% 0.22% $41,806,290
Foresite Capital Management V, LLC 1.3% 1,004,050 0% 37% $40,443,134

Institutional Holders of CG Oncology, Inc. - Common Stock (CGON) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 27,036 $1,116,400 +$420,210 $41.52 5
2025 Q3 77,648,888 $3,127,517,509 +$92,134,469 $40.28 175
2025 Q2 75,914,566 $1,973,784,426 +$139,061,983 $26.00 161
2025 Q1 70,762,639 $1,735,652,621 +$98,334,837 $24.49 141
2024 Q4 66,057,386 $1,894,540,823 +$282,964,154 $28.68 137
2024 Q3 52,183,069 $1,962,909,867 +$277,213,171 $37.73 120
2024 Q2 43,274,514 $1,366,161,770 +$105,145,067 $31.57 109
2024 Q1 38,771,794 $1,702,050,758 +$1,700,470,138 $43.90 96